Our hematopathology experts deliver rigorous diagnostic review of blood, bone marrow, and lymphoid tissue disorders. We provide evidence-based analyses that clarify disease classification, laboratory standards of care, and causation questions in complex litigation.
Contact UsSenior-level clinical and laboratory leadership supporting defensible medical opinions
MD, PhD • Board-Certified Anatomic Pathology & Hematopathology
Our senior hematopathology expert brings over a decade of academic practice evaluating bone marrow, lymph node, and peripheral blood specimens across the spectrum of benign and malignant hematologic disorders. This expert has led manual hematology and immunohistochemistry laboratory operations at a major academic medical center, integrating morphology with flow cytometry, cytogenetics, and molecular diagnostics to resolve challenging cases.
For litigation matters, the expert provides clear, guideline-driven opinions on diagnostic workups, specimen handling, and laboratory quality systems. Extensive publication and editorial experience supports evidence-based testimony and report writing that is both clinically rigorous and accessible to juries and courts.
Oversight of hematology workflows, IHC quality programs, and proficiency testing with a focus on defensible documentation.
Integrated assessment of morphology, flow cytometry, cytogenetics, and molecular findings for hematologic disease classification.
Active contributor to publications and consensus standards that shape modern hematopathology practice.
Objective case review, standards-of-care analysis, and testimony preparation for complex medical disputes.
Evidence-based diagnostic review and laboratory standards analysis for high-stakes matters
Comprehensive reevaluation of bone marrow, lymph node, and peripheral blood specimens, including diagnostic accuracy and disease classification.
Assessment of immunophenotyping strategies, staining quality, and interpretation of flow cytometry and immunohistochemistry data.
Integration of cytogenetic and molecular findings with morphology to evaluate neoplastic risk, prognosis, and treatment relevance.
Review of diagnostic pathways, specimen handling, and laboratory QA/QC protocols to assess compliance with accepted practice.
Objective analysis of complex cytopenias, proliferative disorders, and atypical presentations to clarify alternative explanations.
Clear, defensible opinions supported by current literature, with deposition and trial-ready communication support.
Structured, transparent methods that align with modern hematopathology standards
Review of medical records, laboratory data, and relevant imaging or treatment history.
Detailed assessment of morphology, flow cytometry, IHC, and molecular diagnostics.
Comparison against current classification frameworks and laboratory standards.
Clear, defensible conclusions supported by literature and best practices.
Our team provides clear, evidence-based diagnostic analysis and testimony support.